Advertisement

Vascular abnormalities may progress in branch vein occlusion despite resolution of macular edema

Published:November 19, 2021DOI:https://doi.org/10.1016/j.oret.2021.11.003

      Abstract

      Progression of vascular abnormalities was assessed between resolved and persistent macular edema (ME) in branch retinal vein occlusion. Progression was more common in eyes with resolved ME, suggesting that resolved ME may not signify stability.

      Keywords

      Abbreviations:

      BRVO (branch retinal vein occlusion), ICC (intraclass correlation coefficient), MA (microaneurysms), ME (macular edema), NPA (non-perfused area), NV (neovascularization), UW-FA (ultra-widefield fluorescein angiography), VA (visual acuity), VEGF (vascular endothelial growth factor)
      To read this article in full you will need to make a payment
      Subscribe to Ophthalmology Retina
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Ogura Y, Kondo M, Kadonosono K, Shimura M, Kamei M, Tsujikawa A. Current practice in the management of branch retinal vein occlusion in Japan: survey results of retina specialists in Japan [published correction appears in Jpn J Ophthalmol. 2020;64:321]. Jpn J Ophthalmol. 2019;63:365-373.

        • Tomiyasu T.
        • Hirano Y.
        • Yoshida M.
        • et al.
        Microaneurysms cause refractory macular edema in branch retinal vein occlusion.
        Sci Rep. 2016; 6: 29445
        • Mir T.A.
        • Kherani S.
        • Hafiz G.
        • et al.
        Changes in retinal nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion.
        Ophthalmology. 2016; 123: 625-634.e1
        • Maturi R.K.
        • Glassman A.R.
        • Josic K.
        • et al.
        Effect of intravitreous anti-vascular endothelial growth factor vs sham treatment for prevention of vision-threatening complications of diabetic retinopathy: the protocol W randomized clinical trial.
        JAMA Ophthalmol. 2021; 139: 701-712
        • Tolentino M.J.
        • Miller J.W.
        • Gragoudas E.S.
        • et al.
        Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
        Ophthalmology. 1996; 103: 1820-1828
        • Funk M.
        • Kriechbaum K.
        • Prager F.
        • et al.
        Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.
        Invest Ophthalmol Vis Sci. 2009; 50: 1025-1032
        • Branch Vein Occlusion Study Group
        Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial.
        Arch Ophthalmol. 1986; 104: 34-41